Photograph of Laura M. Kidd Cordova

Government Experience

  • Department of Justice: Criminal Division—Assistant Chief (2013-2016); Trial Attorney (2010-2013)

Education

  • Texas A&M University, B.S. (2000)
  • Georgetown University Law Center, J.D. (2004)
  • Johns Hopkins Bloomberg School of Public Health, M.P.H. (2004)

Admissions

  • District of Columbia
  • New York


Enforcement – Despite a Softening in Regulations, Enforcement Continues


Click to read this article from
Crowell & Moring's Regulatory Forecast 2018
.

Regulatory Forecast 2018

Laura M. Kidd Cordova

,
 Partner Washington, D.C.
lcordova@crowell.com
Phone: +1 202.624.2931
1001 Pennsylvania Avenue NW
Washington, DC 20004-2595

Laura Cordova is an experienced trial lawyer who represents individuals and companies in criminal and civil enforcement actions and related complex civil litigation. Laura’s practice includes conducting internal investigations and representing clients facing government investigations. Laura regularly represents clients in matters involving health care fraud, securities fraud, and procurement fraud and is chair of Crowell & Moring’s False Claims Act practice.

Prior to joining Crowell & Moring, Laura served as Assistant Chief in the Fraud Section of the Criminal Division at the U.S. Department of Justice (DOJ), where she led the Corporate Healthcare Fraud Strike Force charged with investigating and prosecuting large, multi-jurisdictional fraud schemes throughout the U.S. While at DOJ, Laura investigated and tried numerous complex cases involving health care fraud, violations of the Anti-Kickback Statute, mail and wire fraud, money laundering, false statements, and government program fraud.

Representative Matters

  • Represent CEO in parallel DOJ and SEC securities fraud investigations and related derivative and class actions alleging accounting fraud.
  • Represent executive in DOJ False Claims Act investigation related to drug pricing and alleged Anti-Kickback Statute violations.
  • Represent London-based foreign-exchange trader charged in New York with wire fraud for allegedly "front-running" a foreign exchange transaction. Client successfully challenged extradition from the U.K.
  • Represent pharmaceutical sales representative in DOJ False Claims Act investigation related to off-label marketing and violations of the Anti-Kickback Statute.
  • Represent trade organization in parallel criminal and civil DOJ investigations related to health insurance premium assistance programs.
  • Represent non-profit organization in DOJ False Claims Act investigation related to pharmaceutical patient assistance programs.
  • Represent national hospital system in DOJ False Claims Act investigation related to alleged improper diagnosis of patients and multiple related qui tam actions filed.
  • Represent global healthcare company in DOJ False Claims Act investigation related to compliance with federal government contracting requirements.
  • Represent global healthcare company in DOJ False Claims Act investigation related to drug pricing.
  • Represent federal government contractor in Defense Criminal Investigative Services (DCIS) investigation related to labor cost reporting.
  • Conduct internal investigation and represent global agricultural commodity trading company in criminal DOJ and USDA investigation.
  • Conduct internal investigation for national hospital system in response to allegations of Anti-Kickback Statute violations and improper patient inducement.
  • Conduct internal investigation and advise regional hospital system regarding disclosure related to potential billing code errors.
  • Conduct internal investigation and advise health plan regarding disclosure related to compliance with state contract requirements.
  • Conduct internal investigation for government contractor regarding compliance with federal government contracting cybersecurity requirements.


Affiliations

Admitted to practice: District of Columbia, New York



Speeches & Presentations

  • "801 Recent Developments in Individual Criminal and Civil Culpability," HCCA’s 4th Annual Healthcare Enforcement Compliance Conference, Washington, D.C. (November 6, 2018).
  • "Developments in Individual Criminal and Civil Culpability Post-Yates Memorandum," AHLA Fraud and Compliance Forum, Baltimore, MD (September 27, 2018).
  • "The False Claims Act: Civil Investigative Demands and Investigations," Crowell & Moring Webinar (September 12, 2018).
  • "Deep-Dive into Reverse False Claims: Preparing for the Future of False Claims for MCOs," ACI Managed Care Disputes and Litigation Conference, Philadelphia, PA (May 17, 2018).
  • "Healthcare Recovery – It’s Not Just for Healthcare Companies," Crowell & Moring's Fourth Annual In-House Recovery Conference, Dana Point, CA (March 8, 2018).
  • "Pricing Governance and Anticipating Fraud and Abuse Risks in Light of the Current Pricing Debate," 18th Annual Conference On Fraud And Abuse, Boston, MA (March 5, 2018).
  • "Investigations 201: Health Care Fraud and Abuse Investigations," Crowell & Moring Webinar (February 7, 2018).
  • "Ethical Issues that Arise in Parallel Criminal and Civil Proceedings," ABA Section of Litigation Food & Supplements Seventh Annual Workshop, Hershey, PA (June 13, 2017).
  • "False Claims Act: What Every Contractor Needs to Know This Year," OOPS 2017, Crowell & Moring's 33rd Annual Ounce of Prevention Seminar, Washington, D.C. (May 4, 2017).
  • "Administration in Transition, the First 100 Days in Healthcare," Crowell & Moring Webinar (April 18, 2017).
  • "Expectations of the DOJ," SCCE Boston Regional Compliance & Ethics Conference, Boston, MA (March 24, 2017).
  • "Developments with the False Claims Act and Qui Tam Enforcement in Light of the Escobar Decision," ACI - 17th Annual Conference on Fraud and Abuse in the Sale and Marketing of Drugs, Devices, and Medical Technology, Boston, MA (March 6, 2017).
  • "A Spotlight on Recent Trends in Enforcement," CBI 5th Annual Compliance Monitoring (February 7, 2017).
  • U.S. Department of Justice Office of Overseas Prosecutorial Development Assistance, and Training (OPDAT) Presentation to Indonesian Officials (October 2016).
  • "Program Effectiveness – What’s the Government Looking for in Your Compliance Program?" American Health Lawyers Association (October 2016).
  • U.S. Department of Justice Annual National Healthcare Fraud Training Conference (September 2016).
  • "Understand Trends in Recent Enforcement Targets," CBI 10th Annual Forum on Transparency and Aggregate Spend (August 2016).
  • "From the Boardroom to the Big House? How Corporate Compliance and Government Regulations Keep You Safe," Memphis Bar Association (July 2016).
  • U.S. Department of Justice, National Advocacy Center Healthcare Fraud Coordinators’ Conference (May 2016).
  • "U.S. Department of Justice Healthcare Compliance Update," Global Health Care 10th International Pharmaceutical Compliance Congress (May 2016).
  • "U.S. Healthcare Fraud Enforcement," CBI 13th Annual Pharmaceutical Compliance Congress (April 2016).
  • "Emerging Enforcement Trends in Health Care," ABA 30th Annual National Institute on White Collar Crime (March 2016).
  • "Individual Accountability for Corporate Wrongdoing: the Ripple Effect of DAG Yates September Memo and Enforcement that Follows," American Conferences Institute 16th Annual Forum on Fraud and Abuse in the Sales and Marketing of Drugs (March 2016).
  • "Enforcement Panel - Recent Trends and Areas of Focus," CBI 4th Annual Compliance Monitoring (March 2016).


Publications



Client Alerts & Newsletters



In the News



Firm News & Announcements

Feb.08.2017 Laura M. Kidd Cordova, Head of Department of Justice's Corporate Health Care Fraud Strike Force, Joins Crowell & Moring